Pantalla Completa Expandir

OMS da la bienvenida a fármaco que ha reducido a cero infecciones de VIH en tests clínicos AUCKLAND, NEW ZEALAND - SEPTEMBER 10: A measles vaccine is prepared on September 10, 2019 in Auckland, New Zealand. The New Zealand health ministry confirmed 1,051 people have were affected between 1 January and 5 September, 2019. The bulk of cases have been in Auckland in Auckland as health authorities and the Prime Minister implore people to ensure they are vaccinated against the disease. (Photo by Fiona Goodall/Getty Images) (Fiona Goodall/Getty Images)

Un tratamiento bajo investigación en ensayos clínicos podría reducir las dosis de medicamentos que toman los pacientes diagnosticados con virus de inmunodeficiencia humana (VIH), de una pastilla diaria a un inye

See Full Page